When healthcare organisations need lawyers who understand the commercial priorities, regulatory backdrop and challenges facing the sector, they turn to our specialist team.
The fast-paced and innovative nature of the industry, calls for a legal team that:
- Provides sector insight and know-how - new medical advances occur daily. You need lawyers who operate at the forefront of this dynamic sector, helping you to keep abreast of the issues.
- Operates on a global scale - life sciences is global by nature and healthcare is becoming increasingly international. Lawyers need to understand the interplay between jurisdictions and share best practice.
- Navigates the highly regulated landscape - government and regulatory scrutiny is at an all-time high. Increased potential liability relating to your products and services demands high-quality legal advice.
- Understands the central importance of IPR - Patent rights are often central to life sciences corporations. Your lawyers need to recognise the strategic and commercial value of key patents and be ready to defend those key assets through the courts if necessary.
As trusted advisers to some of the sector's biggest players, this is exactly what Wragge Lawrence Graham & Co provides through our dedicated Healthcare and Life Sciences practices.
We give clients a comprehensive healthcare offering. Our team includes healthcare specialists in commissioning, outsourcing, corporate M&A, capital markets, regulatory, data protection, commercial, IP, employment, banking and procurement law.
Our team includes lawyers with a focus on the following areas within healthcare:
- Public sector
- Private sector
The Health and Social Care Act signals the biggest shake-up in the healthcare system since the creation of the NHS. The pressure is on to provide services that are accessible and high-quality in tandem with cutting costs.
From strategic projects through to joint ventures, social enterprises, procurement support and employment-related advice, our team is helping the UK Government offer greater choice and flexibility in the provision of healthcare.
In the private sector, the team boasts industry knowledge and technical expertise, with sector specialists including Karima Hudson, Jon Lent, Andy Stylianou and Ian Piggin.
Leading private healthcare providers and investors call upon our team's M&A, capital markets, finance and private equity experts to deliver major transactions.
We also have extensive experience in advising clients in the care home sector, including those involved in residential care homes, retirement villages and homes for people in need of psychiatric or dementia care.
The team boasts significant experience of advising borrowers and lenders on care home, LD, domiciliary care and specialist unit acquisition and development financings, as well as on the financing and development of private hospitals.
The changing NHS regime brings many complex competition law issues into play. The firm's award-winning Competition & EU team provides specialist advice on a full range of contentious and non-contentious competition law issues.
Advances in communications and IT have yet to fulfil anything like their full potential in healthcare. But, in a world in which the number of mobile phones outnumbers people and where genetics can predict which conditions will strike years before they do, the potential for Connected Health to transform healthcare is enormous.
We are a global leader in Connected Health (eHealth), bringing together specialist expertise in healthcare, life sciences and technology to help our clients maximise opportunities.
Our life sciences experts work with a global client base, helping them to protect and realise value from their products and devices.
Clients include some of the world's leading pharmaceutical giants such as AstraZeneca and GlaxoSmithKline, and the latest biotech start-ups such as arGEN-X, Heptares Therapeutics and Kymab.
They all have sector-specific requirements and need lawyers who can help navigate the heavily regulated landscape. Lawyers with the sector expertise to respond to IP threats quickly and effectively. And lawyers who understand the challenge of recouping investment given the increasing costs to develop drugs and difficulty of getting new products to market.
Fully immersed in the sector, many of us have life sciences degrees and have spent time in our careers as scientists. This means we have the hands-on experience to understand your operating environment, commercial needs and challenges.
'Blockbuster' pharmaceutical products are the life-blood of many pharmaceutical companies. Defending legitimate monopolies protecting such products requires an intimate knowledge of both the procedural aspects and substantive case-law of the Patent Courts - not just in the UK, but across the EU and globally.
Our IP litigators have decades of experience of highly technical patent disputes in the life sciences sector and an impressive record of achieving success for their clients. Whether 'small molecules', 'biosimilars', 'medical devices' or a whole range of other patents types, our team has both the technical and legal background and experience to provide advice of the highest quality.
The desire of the big pharmaceutical companies to fill their pipelines of new drugs, coupled with increasing amounts of money available for early-stage companies, is fuelling a lively transactions market. Trusted advisers to clients across the globe on collaborations and M&A transactions, we lead on the sector's most widely-reported deals.
Speaking at world-leading events such as the BIO Advanced Business Development course at BIO-Europe and BIO in the US, team members are also actively involved in bodies such as the Association of the British Pharmaceutical Industry and the Bioindustry Association. Through this involvement with leading sector bodies, as well as regular contributions to the key professional publications, the team are thought-leaders on the latest issues.